Search Results

LEE011 50mg 50mg  | Purity Not Available

Adooq Bioscience

LEE011 is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

More Information Supplier Page

LEE011 25mg 25mg  | Purity Not Available

Adooq Bioscience

LEE011 is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

More Information Supplier Page

LEE011 10mg 10mg  | Purity Not Available

Adooq Bioscience

LEE011 is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

More Information Supplier Page

PKR Inhibitor 50mg 50mg  | Purity Not Available

Adooq Bioscience

PKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.

More Information Supplier Page

PKR Inhibitor 25mg 25mg  | Purity Not Available

Adooq Bioscience

PKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.

More Information Supplier Page